Virpax Pharmaceuticals
VRPXPre-clinicalVirpax® Pharmaceuticals Inc., (Nasdaq: VRPX) is a specialty pharmaceutical company focused on pioneering advanced healthcare solutions with Probudur, its flagship product leveraging proprietary liposomal encapsulation. Designed for sustained release, Probudur may extend local anesthetic at the wound/incision site, effectively managing post-operative pain for 96 hours as evidenced by non-clinical study data.
VRPX · Stock Price
Historical price data
About
Virpax® Pharmaceuticals Inc., (Nasdaq: VRPX) is a specialty pharmaceutical company focused on pioneering advanced healthcare solutions with Probudur, its flagship product leveraging proprietary liposomal encapsulation. Designed for sustained release, Probudur may extend local anesthetic at the wound/incision site, effectively managing post-operative pain for 96 hours as evidenced by non-clinical study data.
Funding History
1Total raised: $15M
Company Info
Contact
Sectors
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile